Maxim Group analyst Michael Okunewitch maintained a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research Report) yesterday and set a ...

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Hold rating on Nuwellis (NUWE – Research Report). The company’s shares closed yesterday at $1.93. According to TipRanks, ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 46.29% ...

Fintel reports that on November 8, 2024, Maxim Group downgraded their outlook for Gilead Sciences (NasdaqGS:GILD) from Buy to ...

Fintel reports that on November 7, 2024, Maxim Group initiated coverage of Quince Therapeutics (NasdaqGS:QNCX) with a Buy ...

Maxim Group has recently reiterated LendingClub Corp (LC) stock to Buy rating, as announced on October 25, 2024, according to Finviz. Earlier, on October 10, 2024, Keefe Bruyette had raised the stock ...

Sandro Tonali tapped in an early goal to hand Italy a 1-0 away win over Belgium in the Nations League on Thursday that ...

Recognized as a global name in the PR business, Maxim Behar, founder and CEO of M3 Communications Group, Inc., shares his ...

Fintel reports that on November 8, 2024, Maxim Group downgraded their outlook for Gilead Sciences (SNSE:GILD) from Buy to Hold. There are 2,850 funds or institutions reporting positions in Gilead ...

Amazon.com (NASDAQ:AMZN) had its price target increased by research analysts at Maxim Group from $251.00 to $260.00 in a ...

Fintel reports that on November 8, 2024, Maxim Group downgraded their outlook for Gilead Sciences (LSE:0QYQ) from Buy to Hold. As of October 22, 2024, the average one-year price target for Gilead ...

On Friday, Maxim Group adjusted its outlook on Apple Inc. (NASDAQ:AAPL), increasing the stock's price target to $215 from the previous $203, while the Hold rating remains unchanged. The revision ...